Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

185 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
ENETS standardized (synoptic) reporting for molecular imaging studies in neuroendocrine tumours.
Hicks RJ, Dromain C, de Herder WW, Costa FP, Deroose CM, Frilling A, Koumarianou A, Krenning EP, Raymond E, Bodei L, Sorbye H, Welin S, Wiedenmann B, Wild D, Howe JR, Yao J, O'Toole D, Sundin A, Prasad V. Hicks RJ, et al. Among authors: deroose cm. J Neuroendocrinol. 2022 Mar;34(3):e13040. doi: 10.1111/jne.13040. Epub 2021 Oct 20. J Neuroendocrinol. 2022. PMID: 34668262 Free PMC article. Review.
Radioembolization with 90Y Resin Microspheres of Neuroendocrine Liver Metastases: International Multicenter Study on Efficacy and Toxicity.
Braat AJAT, Kappadath SC, Ahmadzadehfar H, Stothers CL, Frilling A, Deroose CM, Flamen P, Brown DB, Sze DY, Mahvash A, Lam MGEH. Braat AJAT, et al. Among authors: deroose cm. Cardiovasc Intervent Radiol. 2019 Mar;42(3):413-425. doi: 10.1007/s00270-018-2148-0. Epub 2019 Jan 2. Cardiovasc Intervent Radiol. 2019. PMID: 30603975
Radioembolization with 90Y Resin Microspheres of Neuroendocrine Liver Metastases After Initial Peptide Receptor Radionuclide Therapy.
Braat AJAT, Ahmadzadehfar H, Kappadath SC, Stothers CL, Frilling A, Deroose CM, Flamen P, Brown DB, Sze DY, Mahvash A, Lam MGEH. Braat AJAT, et al. Among authors: deroose cm. Cardiovasc Intervent Radiol. 2020 Feb;43(2):246-253. doi: 10.1007/s00270-019-02350-2. Epub 2019 Oct 23. Cardiovasc Intervent Radiol. 2020. PMID: 31646375 Free PMC article.
Impact of liver tumour burden, alkaline phosphatase elevation, and target lesion size on treatment outcomes with 177Lu-Dotatate: an analysis of the NETTER-1 study.
Strosberg J, Kunz PL, Hendifar A, Yao J, Bushnell D, Kulke MH, Baum RP, Caplin M, Ruszniewski P, Delpassand E, Hobday T, Verslype C, Benson A, Srirajaskanthan R, Pavel M, Mora J, Berlin J, Grande E, Reed N, Seregni E, Paganelli G, Severi S, Morse M, Metz DC, Ansquer C, Courbon F, Al-Nahhas A, Baudin E, Giammarile F, Taïeb D, Mittra E, Wolin E, O'Dorisio TM, Lebtahi R, Deroose CM, Grana CM, Bodei L, Öberg K, Polack BD, He B, Mariani MF, Gericke G, Santoro P, Erion JL, Ravasi L, Krenning E; NETTER-1 study group. Strosberg J, et al. Among authors: deroose cm. Eur J Nucl Med Mol Imaging. 2020 Sep;47(10):2372-2382. doi: 10.1007/s00259-020-04709-x. Epub 2020 Mar 2. Eur J Nucl Med Mol Imaging. 2020. PMID: 32123969 Free PMC article. Clinical Trial.
ENETS standardized (synoptic) reporting for endoscopy in neuroendocrine tumors.
Borbath I, Pape UF, Deprez PH, Bartsch DK, Caplin M, Falconi M, Garcia-Carbonero R, Grozinsky-Glasberg S, Jensen RT, Arnold R, Ruszniewski P, Toumpanakis C, Valle JW, O Toole D; Members of the Advisory Board of the European Neuroendocrine Tumor Society (ENETS). Borbath I, et al. J Neuroendocrinol. 2022 Mar;34(3):e13105. doi: 10.1111/jne.13105. Epub 2022 Mar 1. J Neuroendocrinol. 2022. PMID: 35233848 Review.
Use and perceived utility of [18 F]FDG PET/CT in neuroendocrine neoplasms: A consensus report from the European Neuroendocrine Tumor Society (ENETS) Advisory Board Meeting 2022.
Ambrosini V, Caplin M, Castaño JP, Christ E, Denecke T, Deroose CM, Dromain C, Falconi M, Grozinsky-Glasberg S, Hicks RJ, Hofland J, Kjaer A, Knigge UP, Kos-Kudla B, Koumarianou A, Krishna B, Lamarca A, Pavel M, Reed NS, Scarpa A, Srirajaskanthan R, Sundin A, Toumpanakis C, Prasad V. Ambrosini V, et al. Among authors: deroose cm. J Neuroendocrinol. 2024 Jan;36(1):e13359. doi: 10.1111/jne.13359. Epub 2023 Dec 14. J Neuroendocrinol. 2024. PMID: 38097193
Clinical management of typical and atypical carcinoids/neuroendocrine tumors in ENETS centres of excellence (CoE): Survey from the ENETS lung NET task force.
Koumarianou A, Filosso PL, Bodei L, Castano JP, Fernandez-Cuesta L, Deroose CM, Foll M, Dromain C, Reed NS, Caplin M, Capdevila J, Falkerby J, Faggiano A, Frilling A, Grande E, Hicks RJ, Kasajima A, Kos-Kudla B, Krishna BA, Lim E, Rinke A, Singh S, Thirlwell C, Volante M, Walter T. Koumarianou A, et al. Among authors: deroose cm. J Neuroendocrinol. 2024 May 16:e13412. doi: 10.1111/jne.13412. Online ahead of print. J Neuroendocrinol. 2024. PMID: 38754956
Altered biodistribution of somatostatin analogues after first cycle of Peptide receptor radionuclide therapy.
Van Binnebeek S, Deroose CM, Baete K, Terwinghe C, Vanbilloen B, Koole M, Haustermans K, Mortelmans L, Verslype C, Van Cutsem E, Verbruggen A, Mottaghy FM. Van Binnebeek S, et al. Among authors: deroose cm. J Clin Oncol. 2011 Jul 1;29(19):e579-81. doi: 10.1200/JCO.2010.34.3384. Epub 2011 May 9. J Clin Oncol. 2011. PMID: 21555687 No abstract available.
Significant impact of transient deterioration of renal function on dosimetry in PRRT.
Van Binnebeek S, Baete K, Terwinghe C, Vanbilloen B, Haustermans K, Mortelmans L, Borbath I, Van Cutsem E, Verslype C, Mottaghy FM, Verbruggen A, Deroose CM. Van Binnebeek S, et al. Among authors: deroose cm. Ann Nucl Med. 2013 Jan;27(1):74-7. doi: 10.1007/s12149-012-0651-y. Epub 2012 Sep 9. Ann Nucl Med. 2013. PMID: 22961123
185 results